A socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Roscongress Foundation is a socially oriented non-financial development institution and a major organizer of international conventions; exhibitions; and business, public, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 160 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 75 countries worldwide.

The Roscongress Foundation has Telegram channels in Russian (t.me/Roscongress), English (t.me/RoscongressDirect), and Spanish (t.me/RoscongressEsp). Official website and Information and Analytical System of the Roscongress Foundation: roscongress.org.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Present-Day Therapy Against Diabetes: Innovations for Improving the Quality of Life
4 June 2021
12:15—13:30
The critical growth rate of diabetes and high risks of complications leading to disability and premature death require taking significant measures at the state level. One of the key objectives is ensuring that innovative treatment is available to the patients. Today, innovative sugar-lowering combination drugs are as revolutionary in treating type 2 diabetes as insulin was a hundred years ago. The issues of technological development, support and stimulus of research and development, clinical research and inclusion of new treatment schemas in clinical recommendations, and improvement of availability of modern drugs are quite critical and require federal support. Ensuring quick access to innovative treatment by the public is, among others, a matter of drug supply financing, expanding lists of benefits, creating patient registers, etc. In the long run, such measures will lead the practice of innovative drug supply to principles of individual approach to each diabetes patient.
● What steps need to be taken for innovative diabetes drugs to be produced in Russia in sufficient quantities?
● What needs to be done for patients to have access to modern drugs manufactured on international markets?
● What mechanisms and regulatory initiatives can stimulate the pharma industry to manufacture innovative drugs?
● What measures can promote increased availability of modern treatment?
● Will resuming the federal diabetes programme promote the goal of providing citizens with innovative treatment and in what way?
Date
04.06.2021
Forum
SPIEF
Started at
12:15—13:30
Conference hall
Pavilion F, Healthy Life Area
Analytics on the topic